Literature DB >> 8464892

Attempts to restore scrapie prion infectivity after exposure to protein denaturants.

S B Prusiner1, D Groth, A Serban, N Stahl, R Gabizon.   

Abstract

A wealth of experimental evidence argues that infectious prions are composed largely, if not entirely, of the scrapie isoform of the prion protein. We attempted to restore scrapie infectivity after exposure to protein denaturants including urea, chaotropic salts, and SDS. None of the procedures restored infectivity. Dialysis to remove slowly chaotropic ions and urea failed to restore scrapie infectivity. Attempts to create monomers of the scrapie isoform of the prion protein under nondenaturing conditions using a wide variety of detergents have been unsuccessful, to date, except for one report claiming that scrapie infectivity could be recovered from 12% polyacrylamide gels after SDS/PAGE [Brown, P., Liberski, P. P., Wolff, A. &amp; Gajdusek, D. C. (1990) Proc. Natl. Acad. Sci. USA 87, 7240-7244]. We found that < 0.001% of the infectious prion titer could be recovered from the region of a polyacrylamide gel where the denatured proteinase K-resistant core of the scrapie isoform of the prion protein and other 30-kDa proteins migrate. We conclude that under the denaturing conditions used for SDS/PAGE, the scrapie isoform of the prion protein is denatured and little or no renaturation occurs upon injection of fractions eluted from gels into animals for bioassays.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464892      PMCID: PMC46182          DOI: 10.1073/pnas.90.7.2793

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Molecular mass, biochemical composition, and physicochemical behavior of the infectious form of the scrapie precursor protein monomer.

Authors:  J Safar; W Wang; M P Padgett; M Ceroni; P Piccardo; D Zopf; D C Gajdusek; C J Gibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 2.  Prion liposomes.

Authors:  R Gabizon; S B Prusiner
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

3.  Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques.

Authors:  M Scott; D Foster; C Mirenda; D Serban; F Coufal; M Wälchli; M Torchia; D Groth; G Carlson; S J DeArmond; D Westaway; S B Prusiner
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

4.  Conservation of infectivity in purified fibrillary extracts of scrapie-infected hamster brain after sequential enzymatic digestion or polyacrylamide gel electrophoresis.

Authors:  P Brown; P P Liberski; A Wolff; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da.

Authors:  C G Bellinger-Kawahara; E Kempner; D Groth; R Gabizon; S B Prusiner
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

Review 6.  Molecular biology of prion diseases.

Authors:  S B Prusiner
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

7.  Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.

Authors:  C R Buchanan; M A Preece; R D Milner
Journal:  BMJ       Date:  1991-04-06

8.  Renaturation of citrate synthase: influence of denaturant and folding assistants.

Authors:  W Zhi; S J Landry; L M Gierasch; P A Srere
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

9.  Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States.

Authors:  J E Fradkin; L B Schonberger; J L Mills; W J Gunn; J M Piper; D K Wysowski; R Thomson; S Durako; P Brown
Journal:  JAMA       Date:  1991-02-20       Impact factor: 56.272

10.  Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells.

Authors:  D R Borchelt; M Scott; A Taraboulos; N Stahl; S B Prusiner
Journal:  J Cell Biol       Date:  1990-03       Impact factor: 10.539

View more
  33 in total

1.  Infectivity of scrapie prions.

Authors:  D M Taylor; K Fernie; P J Steele
Journal:  Mol Med       Date:  1999-10       Impact factor: 6.354

2.  Mimicking dominant negative inhibition of prion replication through structure-based drug design.

Authors:  V Perrier; A C Wallace; K Kaneko; J Safar; S B Prusiner; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

4.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

5.  Transmission of prions.

Authors:  C Weissmann; M Enari; P-C Klöhn; D Rossi; E Flechsig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

6.  Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms.

Authors:  Sotirios Botsios; Sarah Tittman; Laura Manuelidis
Journal:  Virulence       Date:  2015       Impact factor: 5.882

7.  Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry.

Authors:  Eric Vallabh Minikel; Eric Kuhn; Alexandra R Cocco; Sonia M Vallabh; Christina R Hartigan; Andrew G Reidenbach; Jiri G Safar; Gregory J Raymond; Michael D McCarthy; Rhonda O'Keefe; Franc Llorens; Inga Zerr; Sabina Capellari; Piero Parchi; Stuart L Schreiber; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2019-09-26       Impact factor: 5.911

8.  Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity.

Authors:  D Riesner; K Kellings; K Post; H Wille; H Serban; D Groth; M A Baldwin; S B Prusiner
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.

Authors:  K Kaneko; D Peretz; K M Pan; T C Blochberger; H Wille; R Gabizon; O H Griffith; F E Cohen; M A Baldwin; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 10.  Copper and the prion protein: methods, structures, function, and disease.

Authors:  Glenn L Millhauser
Journal:  Annu Rev Phys Chem       Date:  2007       Impact factor: 12.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.